Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New test could pinpoint cause of devastating blood clotting disease

NCT ID NCT04745195

Summary

This study is testing a new laboratory method called the 'HMEC test' to better diagnose the underlying cause of a rare and severe condition called thrombotic microangiopathy (TMA). TMA causes dangerous blood clots in small vessels, often damaging the kidneys and brain. Researchers want to see if this test can more accurately identify patients whose TMA is driven by a problem with their immune system's 'complement' pathway, which could help guide more precise treatment decisions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOTIC MICROANGIOPATHIES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maastricht University Medical Center

    RECRUITING

    Maastricht, Limburg, 6229HX, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.